VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy

Status unconfirmed · Phase 3

Conditions studied: End-stage Heart Failure, Cardiomyopathies

In brief

The purpose of this study is to evaluate the safety and effectiveness of LVADs in providing long-term circulatory support for patients who have chronic stage D heart failure and are ineligible for a heart transplant. This is a multi-center, prospective, randomized, controlled clinical trial, which is comprised of two independent modules.

Key facts

Study ID
NCT00490321
Run by
Ventracor
People needed
225
Starts
2007-06-01
Expected to finish
2012-06-01
Last updated by the study team
2009-09-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.